Impact BioMedical, Inc.
IBO
Last
$4.23
Day
+2.9%
1y
-47.9%
5y
-87.8%
52w
-60.8%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-0627d
EMA 21
5.37
EMA 50
5.73
EMA 200
6.78
20d high
-46.6%
5y high
-94.7%
5y range
0th
Positions held
Your positionsIBO isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-24
Hold
avoid
Signal
Strong Sell
Target
$5.21
Stop
$3.19
Stop distance
24.6%
Target vs last
+23.2%
Fundamentals
| Market cap | $35.11M | Enterprise value | $38.35M | Trailing P/E | 0.37 | Forward P/E | — |
| PEG | — | Price / book | 3.26 | Beta | 2.73 | Dividend yield | 0.00% |
| Revenue growth | -57.1% | Earnings growth | — | Gross margin | 0.0% | Operating margin | -234.0% |
| Profit margin | 22.6% | ROE | 23.5% | ROA | -17.8% | Debt / equity | 0.09 |
| Current ratio | 0.16 | Free cash flow | $1.02M | Analyst recommendation | none | Mean target | — |
| 52w high | $10.51 | 52w low | $4.10 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | -23400.0% | -32700.0% | -16542.9% | -5266.7% | -16471.4% | — |
| Net income | -$0.7M | -$2.3M | $5.2M | -$1.5M | -$14.3M | — |
| Gross margin | 66.7% | — | -5928.6% | 94.4% | 85.7% | — |
| Gross profit | $0.0M | — | -$0.4M | $0.0M | $0.0M | — |
| Operating income | -$0.7M | -$2.3M | -$1.2M | -$0.9M | -$1.2M | — |
- Revenue -57% vs prior quarter ($0.0M vs $0.0M).
- Gross margin 66.7% (was -5928.6% prior quarter).
- Operating margin expanded to -23400%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.1M | — |
| Op margin | -13343.8% | — | — | -6808.0% | — |
| Net income | -$11.8M | -$24.7M | -$4.3M | -$7.1M | — |
| Gross margin | -1225.0% | — | — | — | — |
| Gross profit | -$0.4M | $0.0M | — | — | — |
| Operating income | -$4.3M | -$3.4M | -$4.0M | -$3.4M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsIBO · daily-38.3% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin